XML 77 R50.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Summary of Loss Before Provision for Incomes Taxes
For the years ended December 31, 2025, 2024 and 2023, the loss before income taxes consisted of the following (in thousands):
Year Ended December 31,
202520242023
Domestic$(308,990)$(514,354)$(890,986)
Foreign(4,610)(33,154)(1,954)
Total$(313,600)$(547,508)$(892,940)
Summary of Income Taxes Expenses (Benefit) Incurred During the Period
For the years ended December 31, 2025, 2024 and 2023, the Company recorded the following income tax expense (benefit) (in thousands):
Year Ended December 31,
202520242023
Current:
State$873 $566 $690 
Foreign(346)(109)123 
Total current527 457 813 
Deferred:
Federal— — — 
State— — — 
Foreign(1,364)(936)(884)
Total deferred(1,364)(936)(884)
Income tax benefit$(837)$(479)$(71)
Summary of Reconciliation of the Statutory Corporate Income Tax Rate to the Effective Tax Rate
A reconciliation of income tax benefit computed by applying the 21% statutory U.S. Federal income tax rate to income before income taxes after the adoption of ASU 2023-09 for year ended December 31, 2025 is as follows:
Year Ended December 31,
2025
(in thousands)Percent
Tax at U.S. Statutory Rate$(65,856)21.0 %
State and Local Income Taxes (1)663 (0.2)%
Foreign Tax Effects
Other foreign jurisdictions(743)0.2 %
Nontaxable or Nondeductible Items
Stock compensation14,728 (4.7)%
Limitation on executive compensation1,495 (0.5)%
Gain/Loss on investments3,446 (1.1)%
Other461 (0.1)%
Tax Credits
Research & Development Credits(1,079)0.4 %
Changes in Valuation Allowance45,212 (14.4)%
Other Items
Other836 (0.3)%
Effective tax rate$(837)0.3 %
(1)The states and local jurisdictions that contribute to the majority (greater than 50%) of the tax effect in this category include Massachusetts and New York state and city.

A reconciliation of income tax benefit computed at the statutory corporate income tax rate to the effective income tax rate for the years ended December 31, 2024 and 2023 is as follows:
Year Ended December 31,
20242023
Federal income tax at statutory rate21.0 %21.0 %
State income tax0.1 %1.3 %
Change in valuation allowance(10.4)%13.6 %
Stock-based compensation(7.7)%(14.2)%
Executive compensation0.2 %8.1 %
Tax credits0.5 %0.8 %
Investments in subsidiaries and other(0.6)%(29.0)%
Other(3.0)%(1.6)%
Effective tax rate0.1 %— %
Summary of Deferred Taxes Assets and Liabilities
The Company’s deferred tax assets and liabilities consist of the following (in thousands):
Year Ended December 31,
20252024
Deferred tax assets:
Net operating loss carryforwards$459,420 $332,482 
Tax credit carryforwards63,612 61,497 
Capitalized research and development costs155,755 214,208 
Accrued expenses201 986 
Deferred revenue21,765 28,549 
Stock-based compensation48,809 52,388 
Amortizable intangibles11,755 10,695 
Lease liabilities112,072 116,118 
Investments in subsidiaries59,027 57,534 
Property, plant, and equipment2,464 — 
Other1,257 1,232 
Deferred tax assets before valuation allowance936,137 875,689 
Valuation allowance(840,060)(771,852)
Deferred tax assets, net of valuation allowance96,077 103,837 
Deferred tax liabilities:
Amortizable intangibles(10,119)(11,660)
Property, plant and equipment— (545)
Lease right-of-use assets(92,052)(98,184)
Deferred tax liabilities(102,171)(110,389)
Net deferred taxes$(6,094)$(6,552)
Summary of Deferred Tax Assets Valuation Allowance
Activity in the deferred tax assets valuation allowance is summarized as follows (in thousands):
Beginning of Period
Additions
(Subtractions)
End of Period
Deferred tax assets valuation allowance:
Year ended December 31, 2025$771,852 $68,208 $840,060 
Year ended December 31, 2024$711,778 $60,074 $771,852 
Schedule of Operating Leases Supplemental Cash Flow Information
Supplemental cash flow information related to the Company’s operating leases were as follows (in thousands):
Year Ended December 31,
202520242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$61,178 $45,019 $44,051 
Operating cash flows from finance leases32 83 
Financing cash flows from finance leases354 897 1,295 
The following table presents supplemental cash flow information for each reporting period (in thousands):
Year Ended December 31,
202520242023
Cash paid for interest$$32 $83 
Cash paid for income taxes192 894 670 
Non-cash investing and financing activities:
ROU assets obtained in exchange for new operating lease liabilities336 223,853 27,668 
Purchases of property and equipment included in accounts payable and accrued expenses46 2,565 2,915 
Convertible financial instruments received for Cell Engineering services— — 4,542 
Equity securities and warrants received for Cell Engineering services— 55 17,450 
Common stock issued for acquisitions777 18,245 6,820 
Common stock issued as settlement of contingent consideration liabilities— 14,742 8,896 
Common stock issued for retention payments related to business and asset acquisitions— 5,258 — 
Return of investment in equity securities for reduction in deferred revenue— 6,760 — 
Conversion of notes receivable for common stock— 10,476 — 
Issuance costs related to ATM offering included in accounts payable and accrued expenses53 — — 
For the years ended December 31, 2025, the amount of cash income taxes paid by the Company was as follows (in thousands):

Year Ended December 31,
2025
Federal$— 
State and local:
California12 
South Carolina148 
All other state and local32 
Foreign— 
Cash income taxes, net of refunds$192